Characterization of minority subpopulations in the mutant spectrum of HIV-1 quasispecies by successive specific amplifications

Virus Research

Volumn 129, Issue 2, 2007, Pages 123-134

  García Arriaza, Juan ^a   Domingo, Esteban ^a,b   Briones, Carlos ^b  

^a CENTRO DE BIOLOGÍA MOLECULAR SEVERO OCHOA   (Spain)

^b CENTRO DE ASTROBIOLOGÍA CSIC INTA   (Spain)

Author keywords

HIV 1; Minority genomes; Mutant spectra; RNA virus; Selective PCR; Viral quasispecies

Indexed keywords

DIDANOSINE; INDINAVIR; LAMIVUDINE; ZALCITABINE; ZIDOVUDINE;

ADULT; ARTICLE; CASE REPORT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; MALE; MULTIDRUG RESISTANCE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RETROVIRUS; RNA VIRUS; VIRUS GENOME; VIRUS MUTANT; VIRUS REPLICATION;

ADULT; BASE SEQUENCE; GENOME, VIRAL; HIV INFECTIONS; HIV-1; HUMANS; MALE; MOLECULAR SEQUENCE DATA; MUTATION; PHYLOGENY; VARIATION (GENETICS);

HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES;

EID: 35348887750     PISSN: 01681702     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.virusres.2007.07.001     Document Type: Article

References (87)

1. Airaksinen A., Pariente N., Menendez-Arias L., and Domingo E. Curing of foot-and-mouth disease virus from persistently infected cells by ribavirin involves enhanced mutagenesis. Virology 311 (2003) 339-349
2. Allers K., Knoepfe L.S.A., Rauch P., Walter H., Opravil M., Fischer M., Gunthard H.F., and Metzner K.J. Persistence of lamivudine-sensitive HIV-1 quasispecies in the presence of lamivudine in vitro and in vivo. J. Acquir. Immune Defic. Syndr. 44 (2007) 377-385
3. Amexis G., Oeth P., Abel K., Ivshina A., Pelloquin F., Cantor C.R., Brau A., and Chumakov K. Quantitative mutant analysis of viral quasispecies by chip-based matrix- assisted laser desorption/ionization time-of-flight mass spectrometry. Proc. Natl. Acad. Sci. U.S.A. 98 (2001) 12097-12102
4. Arias A., Ruíz-Jarabo C.M., Escarmís C., and Domingo E. Fitness increase of memory genomes in a viral quasispecies. J. Mol. Biol. 339 (2004) 405-412
5. Barlow K.L., Green J., and Clewley J.P. Viral genome characterisation by the heteroduplex mobility and heteroduplex tracking assays. Rev. Med. Virol. 10 (2000) 321-335
6. Bergroth T., Sonnerborg A., and Yun Z. Discrimination of lamivudine resistant minor HIV-1 variants by selective real-time PCR. J. Virol. Methods 127 (2005) 100-107
7. Boom R., Sol C.J., Salimans M.M., Jansen C.L., Wertheim-van Dillen P.M., and van der Noordaa J. Rapid and simple method for purification of nucleic acids. J. Clin. Microbiol. 28 (1990) 495-503
8. Borrow P., Lewicki H., Wei X., Horwitz M.S., Peffer N., Meyers H., Nelson J.A., Gairin J.E., Hahn B.H., Oldstone M.B., and Shaw G.M. Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus. Nat. Med. 3 (1997) 205-211
9. Briones C., and Bastolla U. Protein evolution in viral quasispecies under selective pressure: a thermodynamic and phylogenetic analysis. Gene 347 (2005) 237-246
10. Briones C., and Soriano V. Different outcome in the first two patients with an HIV-1 multinucleoside drug-resistant T69SSS insertion in Spain. Antivir. Ther. 4 (1999) 125-127
11. Briones C., Mas A., Gómez-Mariano G., Altisent C., Menéndez-Arias L., Soriano V., and Domingo E. Dynamics of dominance of a dipeptide insertion in reverse transcriptase of HIV-1 from patients subjected to prolongued therapy. Virus Res. 66 (2000) 13-26
12. Briones C., Domingo E., and Molina-París C. Memory in retroviral quasispecies: experimental evidence and theoretical model for human immunodeficiency virus. J. Mol. Biol. 331 (2003) 213-229
13. Briones C., de Vicente A., Molina-París C., and Domingo E. Minority memory genomes can influence the evolution of HIV-1 quasispecies in vivo. Gene 384 (2006) 129-138
14. Cai F., Chen H., Hicks C.B., Bartlett J.A., Zhu J., and Gao F. Detection of minor drug-resistant populations by parallel allele-specific sequencing. Nat. Met. 4 (2007) 123-125
15. Charpentier C., Dwyer D.E., Mammano F., Lecossier D., Clavel F., and Hance A.J. Role of minority populations of human immunodeficiency virus type 1 in the evolution of viral resistance to protease inhibitors. J. Virol. 78 (2004) 4234-4247
16. Cherkasova E., Laassri M., Chizhikov V., Korotkova E., Dragunsky E., Agol V.I., and Chumakov K. Microarray analysis of evolution of RNA viruses: evidence of circulation of virulent highly divergent vaccine-derived polioviruses. Proc. Natl. Acad. Sci. U.S.A. 100 (2003) 9398-9403
17. Cline J., Braman J.C., and Hogrefe H.H. PCR fidelity of Pfu DNA polymerase and other thermostable DNA polymerases. Nucleic Acids Res. 24 (1996) 3546-3551
18. Coffin J.M. HIV population dynamics in vivo: implications for genetic variation, pathogenesis and therapy. Science 267 (1995) 483-489
19. Crowder S., and Kirkegaard K. Trans-dominant inhibition of RNA viral replication can slow growth of drug-resistant viruses. Nat. Genet. 37 (2005) 701-709
20. Domingo E. Biological significance of viral quasispecies. Viral Hepat. Rev. 2 (1996) 247-261
21. Domingo E. Viruses at the edge of adaptation. Virology 270 (2000) 251-253
22. Domingo, E. (Ed.), 2006. Quasispecies: concepts and implications for virology. Curr. Top. Microbiol. Immunol. 299.
23. Domingo E., and Gómez J. Quasispecies and its impact on viral hepatitis. Virus Res. 127 (2007) 131-150
24. Domingo E., and Holland J.J. RNA virus mutations and fitness for survival. Annu. Rev. Microbiol. 51 (1997) 151-178
25. Domingo E., Biebricher C.K., Holland J.J., and Eigen M. Quasispecies and RNA Virus Evolution: Principles and Consequences (2001), Landes Bioscience, Austin, TX
26. Domingo E., Ruíz-Jarabo C.M., Sierra S., Arias A., Pariente N., Baranowski E., and Escarmís C. Emergente and selection of RNA virus variants: memory and extinction. Virus Res. 82 (2002) 39-44
27. Doukhan L., and Delwart E. Population genetic analysis of the protease locus of human immunodeficiency virus type 1 quasispecies undergoing drug selection, using a denaturing gradient-heteroduplex tracking assay. J. Virol. 75 (2001) 6729-6736
28. Drake J.W. Rates of spontaneous mutations among RNA viruses. Proc. Natl. Acad. Sci. U.S.A. 90 (1993) 4171-4175
29. Drake J.W., and Holland J.J. Mutation rates among RNA viruses. Proc. Natl. Acad. Sci. U.S.A. 96 (1999) 13910-13913
30. Eigen M. Self-organization of matter and evolution of biological macromolecules. Naturwissenschaften 58 (1971) 465-523
31. Eigen M. On the nature of virus quasispecies. Trends. Microbiol. 4 (1996) 216-218
32. Eigen M., and Biebricher C.K. Sequence space and quasispecies distribution. In: Domingo E., Ahlquist P., and Holland J.J. (Eds). RNA Genetics vol. 3 (1988), CRC, Boca Ratón, FL 211-245
33. Eigen M., and Schuster P. The Hypercycle. A Principle of Natural Self-Organization (1979), Springer, Berlin
34. Felsenstein J. Confidence limits on phylogenies: an approach using the bootstrap. Evolution 39 (1985) 738-791
35. Felsenstein J. PHYLIP (Phylogeny Inference Package) version 3.5 (1991), University of Washington, Seattle
36. Fernández G., Clotet B., and Martínez M.A. Fitness landscape of human immunodeficiency virus type 1 protease quasispecies. J. Virol. 81 (2007) 2485-2496
37. Frater A.J., Chaput C.C., Weber J.N., and McClure M.O. HIV-1 resistance genotyping by sequencing produces inconsistent results for mixed viral populations. AIDS 14 (2000) 1473-1475
38. Gerry N.P., Witowski N.E., Day J., Hammer R.P., Barany G., and Barany F. Universal DNA microarray method for multiplex detection of low abundance point mutations. J. Mol. Biol. 292 (1999) 251-262
39. Gonzalez-Lopez C., Arias A., Pariente N., Gomez-Mariano G., and Domingo E. Preextinction viral RNA can interfere with infectivity. J. Virol. 78 (2004) 3319-3324
40. Guo H., and Xiong J. A specific and versatile genome walking technique. Gene 15 (2006) 18-23
41. Hance A.J., Lemiale V., Izopet J., Lecossier D., Joly V., Massip P., Mammano F., Descamps D., Brun-Vézinet F., and Clavel F. Changes in human immunodeficiency virus type 1 populations after treatment interruption in patients failing antiretroviral therapy. J. Virol. 75 (2001) 6410-6417
42. Imamichi H., Crandall K.A., Natarajan V., Jiang M.K., Dewar R.L., Berg S., Gaddam A., Bosche M., Metcalf J.A., Davey Jr. R.T., and Lane H.C. Human immunodeficiency virus type 1 quasi species that rebound after discontinuation of highly active antiretroviral therapy are similar to the viral quasi species present before initiation of therapy. J. Infect. Dis. 183 (2001) 36-50
43. Ivshina A.V., Vodeiko G.M., Kuznetsov V.A., Volokhov D., Taffs R., Chizhikov V.I., Levandowski R.A., and Chumakov K.M. Mapping of genomic segments of influenza B virus strains by an oligonucleotide microarray method. J. Clin. Microb. 42 (2004) 5793-5801
44. Izopet J., Souyris C., Hance A., Sandres-Saune K., Alvarez M., Pasquier C., Clavel F., Puel J., and Massip P. Evolution of human immunodeficiency virus type 1 populations after resumption of therapy following treatment interruption and shift in resistant genotype. J. Infect. Dis. 185 (2002) 1506-1510
45. Kapoor A., Jones M., Shafer R.W., Rhee S.-Y., Kazanjian P., and Delwart E.L. Sequencing-based detection of low-frequency human immunodeficiency virus type 1 drug-resistant mutants by an RNA/DNA heteroduplex generator-tracking assay. J. Virol. 78 (2004) 7112-7123
46. Karlsson A.C., Gaines H., Sallberg M., Lindback S., and Sonnerborg A. Reappearance of founder virus sequence in human immunodeficiency virus type 1-infected patients. J. Virol. 73 (1999) 6191-6196
47. Kijak G.H., Simon V., Balfe P., Vanderhoeven J., Pampuro S.E., Zala C., Ochoa C., Cahn P., Markowitz M., and Salomon H. Origin of human immunodeficiency virus type 1 quasispecies emerging after antiretroviral treatment interruption in patients with therapeutic failure. J. Virol. 76 (2002) 7000-7009
48. In: Kuiken C.L., Foley B., Hahn B., Korber B., McCutchan F., Marx P.A., Mellors J.W., Mullins J.I., Sodroski J., and Wolinksy S. (Eds). Human Retroviruses and AIDS: A Compilation and Analysis of Nucleic Acid and Amino Acid Sequences (2000), Los Alamos National Laboratory, Los Alamos
49. Larder B.A., Coates K.E., and Kemp S.D. Zidovudine-resistant human immunodeficiency virus selected by passage in cell culture. J. Virol. 65 (1991) 5232-5236
50. Lech W.J., Wang G., Yang Y.L., Chee Y., Dorman K., McCrae D., Lazzeroni L.C., Erickson J.W., Sinsheimer J.S., and Kaplan A.H. In vivo sequence diversity of the protease of human immunodeficiency virus type 1: presence of protease inhibitor-resistant variants in untreated subjects. J. Virol. 70 (1996) 2038-2043
51. Lecossier D., Shulman N.S., Morand-Joubert L., Shafer R.W., Joly V., Zolopa A.R., Clavel F., and Hance A.J. Detection of minoriy populations of HIV-1 expressing the K103N resistance mutations in patients failing nevirapine. J. Acquir. Immune Defic. Syndr. 38 (2005) 37-42
52. Louwagie J., McCutchan F.E., Peeters M., Brennan T.P., Sanders-Buell E., Eddy G.A., van der Groen G., Fransen K., Gershy-Damet G.M., Deleys R., and Burke D.S. Phylogenetic analysis of gag genes from 70 international HIV-1 isolates provides evidence for multiple genotypes. AIDS 7 (1993) 69-78
53. Mansky L.M., and Temin H.M. Lower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse transcriptase. J. Virol. 69 (1995) 5087-5094
54. Martín V., Perales C., Abia D., Ortiz A.R., Domingo E., and Briones C. Microarray-based identification of antigenic variants of foot-and-mouth disease virus: a bioinformatics quality assessment. BMC Genomics 7 (2006) 117
55. Metzner K.J., Bonhoeffer S., Fischer M., Karanicolas R., Allers K., Joos B., Weber R., Hirschel B., Kostrikis L.G., and Gunthard H.F. Emergence of minor populations of human immunodeficiency virus type 1 carrying the M184V and L90M mutations in subjects undergoing structured treatment interruptions. J. Inf. Dis. 188 (2003) 1433-1443
56. Metzner K.J., Raunch P., Walter H., Boesecke C., Zollner B., Jessen H., Schewe K., Fenske S., Gellermann H., and Stellbrink H.J. Detection of minor populations of drug-resistant HIV-1 in acute seroconverters. AIDS 19 (2005) 1819-1825
57. Nájera I., Holguín A., Quiñones-Mateu M.E., Muñoz-Fernández M.A., Nájera R., López-Galíndez C., and Domingo E. Pol gene quasispecies of human-immunodeficiency-virus mutations associated with drug-resistance in virus from patients undergoing no drug-therapy. J. Virol. 69 (1995) 23-31
58. Paolucci S., Baldanti F., Campanini G., Zavattoni M., Cattaneo E., Dossena L., and Gerna G. Analysis of HIV drug-resistant quasispecies in plasma, peripheral blood mononuclear cells and viral isolates from treatment-naive and HAART patients. J. Med. Virol. 65 (2001) 207-217
59. Parker J.D., Rabinovitch P.S., and Burmer G.C. Targeted gene walking polymerase chain reaction. Nucleic Acids Res. 19 (1991) 3055-3060
60. Patick A.K., and Potts K.E. Protease inhibitors as antiviral agents. Clin. Microb. Rev. 11 (1998) 614-627
61. Perales C., Mateo R., Mateu M.G., and Domingo E. Insights into RNA virus mutant spectrum and lethal mutagenesis events: replicative interference and complementation by multiple point mutants. J. Mol. Biol. 369 (2007) 985-1000
62. Pfeiffer J.K., and Kirkegaard K. Increased fidelity reduces poliovirus fitness and virulence under selective pressure in mice. PLoS Pathog. 1 e11 (2005) 102-110
63. Preston B.D., and Dougherty J.P. Mechanisms of retroviral mutation. Trends Microbiol. 4 (1996) 16-21
64. Ratner L., Haseltine W., Patarca R., Livak K.J., Starcich B., Josephs S.F., Doran E.R., Rafalski J.A., Whitehorn E.A., Baumeister K., et al. Complete nucleotide sequence of the AIDS virus, HTLV-III. Nature 313 (1985) 277-284
65. Resch W., Parkin N., Stuelke E.L., Watkins T., and Swanstrom R. A multiple-site-specific heteroduplex tracking assay as a tool for the study of viral population dynamics. Proc. Natl. Acad. Sci. U.S.A. 98 (2001) 176-181
66. Ruíz-Jarabo C.M., Arias A., Baranowski E., Escarmís C., and Domingo E. Memory in viral quasispecies. J. Virol. 74 (2000) 3543-3547
67. Ruíz-Jarabo C.M., Arias A., Molina-París C., Briones C., Baranowski E., Escarmís C., and Domingo E. Duration and fitness dependence of quasispecies memory. J. Mol. Biol. 315 (2002) 285-296
68. Ruíz-Jarabo C.M., Miller E., Gómez-Mariano G., and Domingo E. Synchronous loss of quasispecies memory in parallel viral lineales: a deterministic feature of viral quasispecies. J. Mol. Biol. 333 (2003) 363-553
69. Sagar M., Kirkegaard E., Lavreys L., and Overbaugh J. Diversity in HIV-1 envelope V1-V3 sequences early in infection reflects sequence diversity throughout the HIV-1 genome but does not predict the extent of sequence diversity during chronic infection. AIDS Res. Hum. Retroviruses 22 (2006) 430-437
70. Saitou N., and Nei M. The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol. Biol. Evol. 4 (1987) 406-425
71. Sambrook J., and Russell D.W. Molecular Cloning: A Laboratory Manual. 3rd ed. (2001), Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
72. Sánchez G., Bosch A., Gómez-Mariano G., Domingo E., and Pinto R.M. Evidence for quasispecies distributions in the human hepatitis A virus genome. Virology 315 (2003) 34-42
73. Schuurman R., Demeter L., Reichelderfer P., Tijnagel J., de Groot T., and Boucher C. Worldwide evaluation of DNA sequencing approaches for identification of drug resistance mutations in the human immunodeficiency virus type 1 reverse transcriptase. J. Clin. Microbiol. 37 (1999) 2291-2296
74. Siebert P.D., Chenchik A., Kellog D.E., Lukyanov K.A., and Lukyanov S.A. An improved PCR method for walking in uncloned genomic DNA. Nucleic Acids Res. 23 (1995) 1087-1088
75. Sober E. Reconstructing the Past: Parsimony, Evolution and Inference (1988), MIT Press, Cambridge
76. Strimmer K., and von Haeseler A. Likelihood-mapping: a simple method to visualize phylogenetic content of a sequence alignment. Proc. Natl. Acad. Sci. U.S.A. 94 (1997) 6815-6819
77. Stuyver L., Wyseur A., and Rombout A. Line probe assay for rapid detection of drug-selected mutations in the human immunodeficiency virus type 1 reverse transcriptase gene. Antimicrob. Agents Chemother. 41 (1997) 284-291
78. Tamura K., and Nei M. Estimation of the number of nucleotide substitutions in the control region of mitochondrial DNA in humans and chimpanzees. Mol. Biol. Evol. 10 (1993) 512-526
79. Tapia N., Fernández G., Parera M., Gómez-Mariano G., Clotet B., Quiñones-Mateu M., Domingo E., and Martinez M.A. Combination of a mutagenic agent with a reverse transcriptase inhibitor results in systematic inhibition of HIV-1 infection. Virology 338 (2005) 1-8
80. Temin H.M. A proposal for a new approach to a preventive vaccine against human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. U.S.A. 90 (1993) 4419-4420
81. Thompson J.D., Higgins D.G., and Gibson T.J. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic. Acids Res. 22 (1994) 4673-4680
82. Van Laethem K., Van Vaerenbergh K., Schmit J.C., Sprecher S., Hermans P., de Vroey V., Schuurman R., Harrer T., Witvrouw M., Van Wijngaerden E., Stuyver L., Van Ranst M., Desmyter J., De Clercq E., and Vandamme A.M. Phenotypic assays and sequencing are less sensitive than point mutation assays for detection of resistance in mixed HIV-1 genotypic populations. J. Acquir. Immune Defic. Syndr. 22 (1999) 107-118
83. Vignuzzi M., Stone J.K., Arnold J.J., Cameron C.E., and Andino R. Quasispecies diversity determines pathogenesis through cooperative interactions within a viral population. Nature 439 (2006) 344-348
84. Wang D., Coscoy L., Zylberberg M., Avila P.C., Boushey H.A., Ganem D., and DeRisi J.L. Microarray-based detection and genotyping of viral pathogens. Proc. Natl. Acad. Sci. U.S.A. 99 (2002) 15687-15692
85. Westby M., Lewis M., Whitcomb J., Youle M., Pozniak A.L., James I.T., Jenkins T.M., Perros M., and van der Ryst E. Emergence of CXCR4-using human immunodeficiency virus type 1 (HIV-1) variants in a minority of HIV-1-infected patients following treatment with the CCR5 antagonist Maraviroc Is from a pretreatment CXCR4-using virus reservoir. J. Virol. 80 (2006) 4909-4920
86. Wilson J.W., Bean P., Robins T., Graziano F., and Persing D.H. Comparative evaluation of three human immunodeficiency virus genotyping systems: the HIV-GenotypR Method, the HIV PRT GeneChip Assay, and the HIV-1 RT Line Probe Assay. J. Clin. Microbiol. 38 (2000) 3022-3028
87. Yeni P.G., Hammer S.M., Hirsch M.S., Saag M.S., Schechter M., Carpenter C.C., Fischl M.A., Gatell J.M., Gazzard B.G., Jacobsen D.M., Katzenstein D.A., Montaner J.S., Richman D.D., Schooley R.T., Thompson M.A., Vella S., and Volberding P.A. Treatment for adult HIV infection: 2004 recommendations of the International AIDS Society-USA Panel. JAMA 292 (2004) 251-265